United States Últimas notícias

Stanley Black & Decker (NYSE:SWK) reported third-quarter 2026 sales of $3.7 billion, down 1%, while raising its annual earnings outlook.

Seema Shah, chief global strategist at Principal Asset Management, expects a "really, really volatile environment" through 2027 as she examines what comes next for markets following the US midterm elections. She speaks on "Bloomberg Brief."

ATS (NYSE:ATS) reported fiscal second-quarter 2027 revenue of C$665.8 million, down 8.6%, while posting a C$5 million net loss.

LivaNova (NASDAQ:LIVN) reported third-quarter 2026 revenue of $393.1 million, up 9.9% year over year, while raising its annual financial guidance.

NICE (NASDAQ:NICE) reported third-quarter 2026 revenue of $790.7 million, up 8%, while adjusted earnings exceeded Wall Street expectations.

Data center developers seeking to build dozens of artificial intelligence campuses across Texas are facing their worst-case scenario under newly-elected Democratic Governor Gina Hinojosa, who has called for an immediate moratorium on data center development. Bloomberg's Tom Giles breaks down what the midterm election results could mean for the tech sector.

Democratic candidates celebrated victories across the US as the party swept key races in Tuesday's midterm elections. Winning speeches included Democrats who flipped seats in states long-held by Republican candidates, including Texas, Ohio and South Carolina.

AES (NYSE:AES) reported third-quarter 2026 revenue of $3.87 billion, up 15.5%, while earnings exceeded Wall Street expectations.

Republican candidates and lawmakers struck varying tones from defiant to tearful following Tuesday's midterm elections, with several celebrating GOP victories and others reflecting on hard-fought races across key states. (Corrects to replace incorrect headline and description.)

Autohome (NYSE:ATHM) reported third-quarter 2026 net revenue of RMB1.315 billion, down 26%, as earnings and operating profit declined.

Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema. "We are hopeful that we will be able to get the timely approval from the FDA at the end of this year and launch it at the beginning of next year," Doustdar says. He speaks on Bloomberg Television after the company boosted its forecast for the year once again, sparking optimism after the new Wegovy pill and the older shot Ozempic helped buoy earnings.

Cadeler (NYSE:CDLR) signed a contract to support installing 87 offshore wind turbines at Dogger Bank C, beginning in Q3 2027.